TOP2A

DNA topoisomerase II alpha, the group of Topoisomerases

Basic information

Region (hg38): 17:40388524-40417896

Previous symbols: [ "TOP2" ]

Links

ENSG00000131747NCBI:7153OMIM:126430HGNC:11989Uniprot:P11388AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TOP2A gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TOP2A gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
7
clinvar
5
clinvar
12
missense
45
clinvar
11
clinvar
56
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
0
Total 0 0 45 18 5

Variants in TOP2A

This is a list of pathogenic ClinVar variants found in the TOP2A region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
17-40389558-T-C not specified Uncertain significance (Apr 06, 2024)3328050
17-40389575-G-A not specified Uncertain significance (Oct 10, 2023)3181191
17-40389582-T-G not specified Uncertain significance (Dec 27, 2022)2254908
17-40389970-T-C not specified Uncertain significance (Sep 15, 2021)2290462
17-40390022-A-C TOP2A-related disorder Benign (May 30, 2019)3058908
17-40390108-T-C not specified Uncertain significance (May 12, 2024)3328051
17-40390129-T-C not specified Uncertain significance (Feb 10, 2022)2281352
17-40390141-C-A not specified Uncertain significance (Apr 26, 2023)2517067
17-40390141-C-T not specified Uncertain significance (Dec 18, 2023)3181190
17-40391509-T-G not specified Uncertain significance (May 18, 2023)2508622
17-40391561-T-C Likely benign (Sep 01, 2022)2647737
17-40392074-C-T not specified Likely benign (Oct 17, 2023)3181189
17-40392094-A-G not specified Uncertain significance (Mar 29, 2022)2280298
17-40392210-A-G Benign (Jun 23, 2018)715785
17-40392277-A-C Benign (Dec 31, 2019)768879
17-40392296-G-A not specified Uncertain significance (Nov 18, 2022)2390897
17-40392298-G-T not specified Uncertain significance (Aug 11, 2022)3181188
17-40392315-C-A not specified Uncertain significance (Dec 30, 2023)3181187
17-40392335-G-C not specified Uncertain significance (Oct 13, 2023)3181186
17-40392626-A-G not specified Uncertain significance (Oct 10, 2023)3181185
17-40392636-C-T not specified Uncertain significance (Jan 16, 2024)3181184
17-40392726-T-C not specified Uncertain significance (May 16, 2024)3328052
17-40395481-T-C not specified Uncertain significance (Nov 21, 2023)3181183
17-40396312-C-A not specified Uncertain significance (Jan 17, 2024)3181182
17-40396314-T-C not specified Uncertain significance (Apr 22, 2022)2284842

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TOP2Aprotein_codingprotein_codingENST00000423485 3529435
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9910.009141246090451246540.000181
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense4.044487620.5880.000037810175
Missense in Polyphen84275.110.305343647
Synonymous1.702212560.8650.00001262692
Loss of Function6.751580.20.1870.000004371057

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0005560.000540
Ashkenazi Jewish0.0001030.0000993
East Asian0.00006180.0000556
Finnish0.00004690.0000464
European (Non-Finnish)0.0002010.000195
Middle Eastern0.00006180.0000556
South Asian0.0003410.000294
Other0.0001650.000165

dbNSFP

Source: dbNSFP

Function
FUNCTION: Control of topological states of DNA by transient breakage and subsequent rejoining of DNA strands. Topoisomerase II makes double-strand breaks. Essential during mitosis and meiosis for proper segregation of daughter chromosomes. May play a role in regulating the period length of ARNTL/BMAL1 transcriptional oscillation (By similarity). {ECO:0000250|UniProtKB:Q01320, ECO:0000269|PubMed:18790802, ECO:0000269|PubMed:22013166, ECO:0000269|PubMed:22323612}.;
Pathway
Doxorubicin Pathway (Cancer Cell), Pharmacodynamics;Etoposide Pathway, Pharmacokinetics/Pharmacodynamics;Etoposide Action Pathway;Teniposide Action Pathway;Teniposide Metabolism Pathway;Etoposide Metabolism Pathway;Mitotic G1-G1-S phases;Gastric Cancer Network 1;Gastric Cancer Network 2;Retinoblastoma (RB) in Cancer;Post-translational protein modification;SUMOylation of DNA replication proteins;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;Transcription of E2F targets under negative control by DREAM complex;G0 and Early G1;Mitotic G1-G1/S phases;SUMOylation;Cell Cycle;Cell Cycle, Mitotic;Validated transcriptional targets of deltaNp63 isoforms (Consensus)

Recessive Scores

pRec
0.545

Intolerance Scores

loftool
0.689
rvis_EVS
0.49
rvis_percentile_EVS
79.61

Haploinsufficiency Scores

pHI
hipred
Y
hipred_score
0.756
ghis
0.592

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.960

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Top2a
Phenotype

Zebrafish Information Network

Gene name
top2a
Affected structure
neural tube
Phenotype tag
abnormal
Phenotype quality
apoptotic

Gene ontology

Biological process
resolution of meiotic recombination intermediates;sister chromatid segregation;hematopoietic progenitor cell differentiation;DNA topological change;DNA ligation;cellular response to DNA damage stimulus;chromosome segregation;female meiotic nuclear division;apoptotic chromosome condensation;embryonic cleavage;regulation of circadian rhythm;positive regulation of apoptotic process;mitotic DNA integrity checkpoint;positive regulation of single stranded viral RNA replication via double stranded DNA intermediate;positive regulation of transcription by RNA polymerase II;rhythmic process;negative regulation of DNA duplex unwinding
Cellular component
nuclear chromosome;condensed chromosome;nucleus;nucleoplasm;nucleolus;centriole;DNA topoisomerase complex (ATP-hydrolyzing);viral integration complex;protein-containing complex;ribonucleoprotein complex
Molecular function
magnesium ion binding;DNA binding;chromatin binding;RNA binding;DNA topoisomerase type II (ATP-hydrolyzing) activity;protein kinase C binding;protein binding;ATP binding;protein C-terminus binding;DNA-dependent ATPase activity;drug binding;DNA binding, bending;enzyme binding;protein homodimerization activity;histone deacetylase binding;ubiquitin binding;protein heterodimerization activity